Year: 2021
Type: article
Abstract: respectively, during the year of publication or the prior 2 calendar years that were not disclosed with the article.Discussion | In this cross-sectional study, we found that 15% of authors of editorial commentaries accompanying RCTs on invasive cardiovascular interventions published from 2013 to 2019 reported financial associations with trial sponsors.Many of the authors with general payments or research funding reported on Open Payments did not disclose all of these financial associations in the commentary nor the accompanying disclosure forms.A limitation of this study is that the Open Payments database does not capture financial associations with industry for non-US-based authors.For this reason, 83 (58%) of the commentary authors did not have Open Payments records.The present analysis was also limited because it may not have captured all recent financial associations of authors with industry or trial sponsors, could not account for inaccuracies in the Open Payments data, and did not study nonfinancial associations.The disclosed and undisclosed financial associations with trial sponsors for a substantial number of editorial commentaries on RCTs of invasive cardiovascular interventions are concerning, all the more so because of the attention focused on the issue since the 1990s.2 As the financial associations of authors diminish the value of the commentaries, journal editors should strengthen their disclosure requirements, improve compliance, and consider once again whether they should allow authors to have such financial associations at all.
Source: JAMA Internal Medicine
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3197784033